Tissue Expression and Serum Concentrations of Amphiregulin and Epiregulin in Ovarian Endometrioma: A Pilot Case–Control Study
Year: 2026
Type: article
Abstract: Background: Amphiregulin (AREG) and epiregulin (EREG) are epidermal growth factor family ligands involved in inflammation, cellular proliferation, and tissue remodeling. This pilot study compared tissue AREG and EREG mRNA expression and circulating protein concentrations between women with ovarian endometriomas and those with non-endometriotic benign ovarian cysts. Methods: This case–control study included 28 women undergoing ovarian cystectomy: 14 with histologically confirmed endometriomas and 14 with non-endometriotic benign ovarian cysts. Tissue mRNA expression was assessed using quantitative real-time PCR, and preoperative serum protein concentrations were measured by ELISA. Between-group comparisons used Mann–Whitney U tests with Benjamini–Hochberg adjustment. Exploratory analyses included within-endometrioma Spearman correlations and receiver operating characteristic analyses. Results: Median tissue AREG expression was 11.74 versus 0.83 (q < 0.001), and EREG expression was 1.95 versus 0.82 (q = 0.0105), with variable individual control values. CA125 was higher in endometrioma (50.30 versus 17.70; q = 0.0058). Serum EREG did not differ significantly (q = 0.2855). Serum AREG was lower in a sensitivity analysis assigning four right-censored observations to 1000 pg/mL (127.26 versus 296.02 pg/mL; q = 0.0149). Apparent tissue Area under the curve (AUC) were 0.992 for AREG and 0.827 for EREG. None of the six exploration within-endometrioma correlations reached unadjusted p < 0.05. Conclusions: Higher tissue AREG and EREG mRNA expressions were observed in ovarian endometrioma patients. The serum AREG finding depends on handling right-censored measurements. Small sample size, tissue heterogeneity, incomplete assay verification, and lack of independent validation limit biological and diagnostic interpretations.
Source: Biomedicines
Institutions: Balıkesir University, Dokuz Eylül University, University of Turku
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7234562073
